Atlas Trials

Retrospective Study Assessment Treatment Response Faslodex®( 500 mg)

Clinical trial NCT01509625 · COMPLETED

Trial details

NCT number
NCT01509625
Sponsor
Isabel Blancas
Status
COMPLETED
Study type
OBSERVATIONAL
Malignant Neoplasm of Breast Stage IV
Start date
2012-01-01
Primary completion
2014-01-01
Enrollment
272

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.